Revenues of Yubo International Biotech Ltd from 30 Nov 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Yubo International Biotech Ltd quarterly and annual Revenues in USD history and change rate from 30 Nov 2010 to 30 Sep 2025.
  • Yubo International Biotech Ltd Revenues for the quarter ending 30 Sep 2025 was $0.
  • Yubo International Biotech Ltd Revenues for the twelve months ending 30 Sep 2025 was $18, a 100% decline year-over-year.
  • Yubo International Biotech Ltd annual Revenues for 2024 was $3,470, a 99% decline from 2023.
  • Yubo International Biotech Ltd annual Revenues for 2023 was $604,676, a 480% increase from 2022.
  • Yubo International Biotech Ltd annual Revenues for 2022 was $104,283, a 92% decline from 2021.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

Yubo International Biotech Ltd Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $18 $0 $0 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $18 $0 $0 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $18 $0 -$3,488 -100% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $3,470 $18 -$18,139 -100% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $21,609 $0 -$428,510 -100% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q2 2024 $450,119 $0 -$1,430 -100% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $451,549 $3,488 -$153,127 -98% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $604,676 $18,121 -$48,399 -73% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $653,075 $428,510 +$413,930 +2839% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $239,145 $1,430 -$6,540 -82% 01 Apr 2023 30 Jun 2023 10-Q 19 Aug 2024 2024 Q2
Q1 2023 $245,685 $156,615 +$141,402 +929% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q4 2022 $104,283 $66,520 01 Oct 2022 31 Dec 2022 10-K 12 Apr 2024 2023 FY
Q3 2022 $14,580 -$83,723 -85% 01 Jul 2022 30 Sep 2022 10-Q 20 Nov 2023 2023 Q3
Q2 2022 $7,970 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $15,213 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $98,303 +$98,303 01 Jul 2021 30 Sep 2021 10-Q 16 Nov 2022 2022 Q3
Q4 2020 $0 $0 $0 01 Sep 2020 30 Nov 2020 10-Q 19 Jan 2021 2021 Q3
Q3 2020 $0 $0 $0 01 Jun 2020 31 Aug 2020 10-Q 20 Oct 2020 2021 Q2
Q2 2020 $0 $0 $0 01 Mar 2020 31 May 2020 10-Q 20 Jul 2020 2021 Q1
Q1 2020 $0 $0 $0 01 Dec 2019 29 Feb 2020 10-KT 23 Apr 2021 2020 FY
Q4 2019 $0 $0 $0 01 Sep 2019 30 Nov 2019 10-Q 19 Jan 2021 2021 Q3
Q3 2019 $0 $0 $0 01 Jun 2019 31 Aug 2019 10-Q 20 Oct 2020 2021 Q2
Q2 2019 $0 $0 $0 01 Mar 2019 31 May 2019 10-Q 20 Jul 2020 2021 Q1
Q1 2019 $0 $0 $0 01 Dec 2018 28 Feb 2019 10-KT 23 Apr 2021 2020 FY
Q4 2018 $0 $0 $0 01 Sep 2018 30 Nov 2018 10-Q 13 Jan 2020 2020 Q3
Q3 2018 $0 $0 $0 01 Jun 2018 31 Aug 2018 10-Q 11 Oct 2019 2020 Q2
Q2 2018 $0 $0 $0 01 Mar 2018 31 May 2018 10-Q 11 Jul 2019 2020 Q1
Q1 2018 $0 $0 $0 01 Dec 2017 28 Feb 2018 10-K 12 Jun 2019 2019 FY
Q4 2017 $0 $0 $0 01 Sep 2017 30 Nov 2017 10-Q 11 Jan 2019 2019 Q3
Q3 2017 $0 $0 $0 01 Jun 2017 31 Aug 2017 10-Q 12 Oct 2018 2019 Q2
Q2 2017 $0 $0 $0 01 Mar 2017 31 May 2017 10-Q 16 Jul 2018 2019 Q1
Q1 2017 $0 $0 $0 01 Dec 2016 28 Feb 2017 10-K 13 Jun 2018 2018 FY
Q4 2016 $0 $0 $0 01 Sep 2016 30 Nov 2016 10-Q 16 Jan 2018 2018 Q3
Q3 2016 $0 $0 $0 01 Jun 2016 31 Aug 2016 10-Q 16 Oct 2017 2018 Q2
Q2 2016 $0 $0 $0 01 Mar 2016 31 May 2016 10-Q 14 Jul 2017 2018 Q1
Q1 2016 $0 $0 $0 01 Dec 2015 29 Feb 2016 10-K 14 Jun 2017 2017 FY
Q4 2015 $0 $0 $0 01 Sep 2015 30 Nov 2015 10-Q 13 Jan 2017 2017 Q3
Q3 2015 $0 $0 $0 01 Jun 2015 31 Aug 2015 10-Q 12 Oct 2016 2017 Q2
Q2 2015 $0 $0 $0 01 Mar 2015 31 May 2015 10-Q 12 Jul 2016 2017 Q1
Q1 2015 $0 $0 $0 01 Dec 2014 28 Feb 2015 10-K 10 Jun 2016 2016 FY
Q4 2014 $0 $0 $0 01 Sep 2014 30 Nov 2014 10-Q 14 Jan 2016 2016 Q3
Q3 2014 $0 $0 $0 01 Jun 2014 31 Aug 2014 10-Q 06 Oct 2015 2016 Q2
Q2 2014 $0 $0 $0 01 Mar 2014 31 May 2014 10-Q 09 Jul 2015 2016 Q1
Q1 2014 $0 $0 01 Dec 2013 28 Feb 2014 10-K 15 Jun 2015 2015 FY
Q4 2013 $0 01 Sep 2013 30 Nov 2013 10-Q 14 Jan 2015 2015 Q3
Q3 2013 $0 01 Jun 2013 31 Aug 2013 10-Q 17 Oct 2014 2015 Q2
Q2 2013 $0 $0 01 Mar 2013 31 May 2013 10-Q 23 Jun 2014 2015 Q1
Q2 2012 $0 $0 01 Mar 2012 31 May 2012 10-Q 12 Jul 2012 2012 Q1
Q4 2011 $0 $0 01 Sep 2011 30 Nov 2011 10-Q 12 Jan 2012 2011 Q3
Q2 2011 $0 01 Mar 2011 31 May 2011 10-Q 12 Jul 2012 2012 Q1
Q4 2010 $0 01 Sep 2010 30 Nov 2010 10-Q 12 Jan 2012 2011 Q3

Yubo International Biotech Ltd Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,470 -$601,206 -99% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $604,676 +$500,393 +480% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $104,283 -$1,140,090 -92% 01 Jan 2022 31 Dec 2022 10-K 12 Apr 2024 2023 FY
2021 $1,244,373 01 Jan 2021 31 Dec 2021 10-K 14 Apr 2023 2022 FY
2019 $0 $0 01 Mar 2019 29 Feb 2020 10-KT 23 Apr 2021 2020 FY
2018 $0 $0 01 Mar 2018 28 Feb 2019 10-KT 23 Apr 2021 2020 FY
2017 $0 $0 01 Mar 2017 28 Feb 2018 10-K 12 Jun 2019 2019 FY
2016 $0 $0 01 Mar 2016 28 Feb 2017 10-K 13 Jun 2018 2018 FY
2015 $0 $0 01 Mar 2015 29 Feb 2016 10-K 14 Jun 2017 2017 FY
2014 $0 $0 01 Mar 2014 28 Feb 2015 10-K 10 Jun 2016 2016 FY
2013 $0 01 Mar 2013 28 Feb 2014 10-K 15 Jun 2015 2015 FY
2011 $0 $0 01 Mar 2011 28 Feb 2012 10-K 11 Jun 2012 2011 FY
2010 $0 01 Mar 2010 28 Feb 2011 10-K 11 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.